Quarterly report pursuant to Section 13 or 15(d)

STOCK OPTIONS (Details Narrative)

v3.22.2.2
STOCK OPTIONS (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 08, 2022
May 05, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Stock price     $ 2.50   $ 2.50  
Stock compensation expense     $ 15,495 $ 3,686 $ 68,377 $ 8,715
Stock compensation expense unamortized         $ 11,683  
Weighted average remaining life         19 years  
Fair value of warrant     $ 86,821   $ 86,821  
Purchase of common stock, shares         48,309  
Number of stock option shares, vested         28,003  
Consultant [Member]            
Number of stock option shares, vested         6,253  
Stock option         $ 14,644  
Vesting period         3 years  
Director [Member]            
Number of stock option shares, vested         21,750  
Stock option         $ 65,415  
Vesting period         5 years  
2014 Equity Incentive Plan [Member]            
Common stock shares issued         290,879  
Plan termination term         10 years  
Number of stock option shares, vested         145,000  
Option grantable     145,879   145,879  
Percent of issued and outstanding shares         20.00%  
2016 Equity Incentive Plan [Member]            
Common stock shares issued         656,250  
Plan termination term         10 years  
Number of stock option shares, vested         330,350  
Option grantable     325,900   325,900  
2018 Equity Incentive Plan [Member]            
Common stock shares issued         450,000  
Plan termination term         10 years  
Number of stock option shares, vested         380,008  
Option grantable     69,992   69,992  
2022 Equity Incentive Plan [Member]            
Common stock shares issued         695,000  
Plan termination term         10 years  
Number of stock option shares, vested         11,276  
Option grantable     683,724   683,724  
DeCsepel 2022 Subscription Agreement | Warrants            
Purchase of common stock, shares   165,929        
Common stock, par value   $ 0.001        
Aggregate warrant amount   $ 250,000        
Purchase price, per share   $ 2.26        
Common stock shares issued   110,619        
Exercise price   $ 6.00        
Plan termination term   3 years        
Kent Emry [Member]            
Fair value of warrant $ 214,975       $ 214,975  
Purchase of common stock, shares         119,617